AAMI DEVICE GMP COMPLIANCE COURSES EXPECTED TO BEGIN THIS FALL; FDA SHOWING INTEREST IN GROUP'S PROGRAM AS MEANS FOR CERTIFYING THIRD-PARTY INSPECTORS
This article was originally published in The Gray Sheet
Executive SummaryThe Association for the Advancement of Medical Instrumentation is developing literature that it plans to use in future educational courses on device good manufacturing practices requirements. The literature and courses will be geared toward independent auditing groups as well as internal company officials responsible for GMP compliance.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.